Filter
83
Filtered Results: 83
Text search:
Lamontagne
E.
Featured
Recommendations
26
New Publications
18
Language
Document type
Guidelines
39
No document type
29
Studies & Reports
8
Training Material
3
Manuals
2
Strategic & Response Plan
1
Fact sheets
1
Countries / Regions
Global
4
Congo, Democratic Republic of
4
Russia
4
Rwanda
3
Guinea
3
Brazil
3
Sierra Leone
2
Senegal
2
Burkina Faso
2
Mozambique
2
Guinea-Bissau
2
Latin America and the Carribbean
2
Yemen
2
Angola
2
Liberia
2
Kenya
1
Benin
1
Togo
1
Syria
1
Nigeria
1
Niger
1
Burundi
1
Africa
1
West and Central Africa
1
Middle East and North Africa
1
Gabon
1
France
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Mali
1
South Sudan
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
14
Key Resources
14
Public Health
6
Clinical Guidelines
3
Women & Child Health
3
Capacity Building
1
Toolboxes
COVID-19
32
Ebola & Marburg
13
Cholera
6
HIV
5
Rapid Response
3
Mental Health
3
Natural Hazards
1
Disability
1
Caregiver
1
Health Financing Toolbox
1
Временные рекомендации
13 марта 2020 г.
Настоящий документ является вторым изданием руководства (версия 1.2), которое первоначально представляло собой адаптированн...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Large File: 85 MB!!!. Please download directly from the website link
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
24 marzo 2020
El objetivo de este documento es elaborar una lista de medicamentos esenciales para manejar los pacientes en unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID -19. Incluye principios activos con su forma farmacéutica y concentración —preferentemente e...
BMC Medicine 2014, 12:196
http://www.biomedcentral.com/1741-7015/12/196
Mental disorders impose an enormous burden on society, accounting for almost one in three years lived with disability globally. •In addition to their health impact, mental disorders cause a significant economic burden due to lost economic output and the link between mental disorders and costly, po...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Update, 23 de junio de 2022
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Ces lignes directrices provisoires présentent quelques principes de base en matière de prise en charge nutritionnelle adaptée aux patients adultes et pédiatriques pendant leur traitement et leur convalescence dans les unités de traitement Ebola, dans les centres de soins communautaires et autre...
This clinical management manual for Ebola Viral Disease in Liberia was developed after several ETUs were established in the country following the outbreak early this year. As the outbreak evolved, it became evident that different SOPs were being used by clinicians across these treatment facilities. ...
A call for national and regional containment, recovery and prevention
Curr HIV/AIDS Rep. 2022; 19(1): 37–45.
Published online 2022 Jan 29. doi: 10.1007/s11904-021-00589-4.
COVID-19 has had an unprecedented impact on the cascade-of-care among PLWH in LAC. There is a need for
longitudinal studies that assess clinic implication of these pandemic interactions in LAC.
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
Цель настоящего документа - дать указания по очистке и дезинфекции поверхностей окружающей среды в контексте КОВИД-19. Настоящее руководство предназначено для раб...
